MATTHEW DOWNEY: Open Payments
NPI 1215662184 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 30 payments from 12 companies in 2025. Trend: 2023 $206 · 2024 $1,160 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $213 |
| Merit Medical Systems Inc | 1 | $128 |
| AstraZeneca Pharmaceuticals LP | 6 | $99 |
| ABBVIE INC. | 5 | $97 |
| Exact Sciences Corporation | 2 | $41 |
| PFIZER INC. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Eisai Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Boston Scientific Corporation | 1 | $23 |
Products named: Wegovy, ESOPHYX, AIRSUPRA, Ozempic, QULIPTA, The Cologuard Plus Collection Kit, VRAYLAR, XIFAXAN.
Industry payments across AZ — which companies pay providers there.
